Dergiler / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 4

Use of Saffron Against Dementia and MemoryImpairment in Traditional Persian Medicine: A Historical Perspective

Sayfa
412–416
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

After him, other great scholars includingIbnSina, Ibn Elias Shirazi, and Dawood ibn Omar Antaki developed saffron-based formulas to improve the memory status ofpatients with forgetfulness.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:In the last century, dementia became one of the most widespread diseases due to the aging world population.
📊
Temel Bulgular & Veri:In reviewing these books, in theeighth century CE, three centuries before Avicenna, Ibn Hakam from Damascus was the first physician who deliberated therole of saffron in the treatment of dementia in his book Haroniye (Aaron’s book).
💡
Sonuç & Katkı:After him, other great scholars includingIbnSina, Ibn Elias Shirazi, and Dawood ibn Omar Antaki developed saffron-based formulas to improve the memory status ofpatients with forgetfulness.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

In the last century, dementia became one of the most widespread diseases due to the aging world population. Alzheimer’sdisease is the most common type of dementia. Persian medical literatures have discussed disorders such as forgetfulness andtheir treatment under the topic “Nesian.” Causes of these medical conditions have been also categorized. Poor memoryand improving its treatment methods have long been important in traditional medical teaching. For example, saffron is oneof the herbs used as a memory enhancer, and it has been cited many times in the related literature. This study sought toconsider the history of saffron in the treatment of dementia by examining authentic books of traditional Persian medicineand by describing examples of medicinal compounds affecting saffron-based medications. In reviewing these books, in theeighth century CE, three centuries before Avicenna, Ibn Hakam from Damascus was the first physician who deliberated therole of saffron in the treatment of dementia in his book Haroniye (Aaron’s book). After him, other great scholars includingIbnSina, Ibn Elias Shirazi, and Dawood ibn Omar Antaki developed saffron-based formulas to improve the memory status ofpatients with forgetfulness.

🔖

Bu Makaleye Atıf Yap

Marzabadi, L. R., MOHAMMADİNASAB, R., SHA'RBAF, J. G., Araj-KHODAEİ, M., FAZLJOU, S. M. B., TALEBİ, M., ETEGHAD, S. S. (2022). Use of Saffron Against Dementia and MemoryImpairment in Traditional Persian Medicine: A Historical Perspective. Erciyes Medical Journal, Cilt: 43 - Sayı: 4, 412–416. https://ajindex.com/articles/502284

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Sattin D, Leonardi M, Picozzi M. The autonomic nervous system and the brainstem: A fundamental role or the background actors for consciousness generation? Hypothesis, evidence, and future directions for rehabilitation and theoretical approaches. Brain Behav 2020; 10(1): e01474
  2. Davis DH. Dementia: sociological and philosophical constructions. Soc Sci Med 2004; 58(2): 369–78
  3. Neary D, Snowden JS, Northen B, Goulding P. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51(3): 353–61
  4. World Health Organization. Global action plan on the public health response to dementia 2017–2025. Available from: URL: https://apps. who.int/iris/bitstream/handle/10665/259615/9789241513487-e ng.pdf?sequence=1
  5. World Health Organization. Dementia: a public health priority, 2012. Available from: URL:
  6. Román GC, Royall DR. A diagnostic dilemma: is “Alzheimer’s dementia” Alzheimer’s disease, vascular dementia, or both?. Lancet Neurol 2004; 3(3): 141
  7. Amieva H, Lafont S, Auriacombe S, Rainville C, Orgogozo JM, Dartigues JF, et al. Analysis of error types in the trial making test evidences an inhibitory deficit in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1998; 20(2): 280–5
  8. Román GC. Defining dementia: clinical criteria for the diagnosis of vascular dementia. Acta Neurol Scand Suppl 2002; 178: 6–9
  9. Gismondi A, Fanali F, Labarga JMM, Grilli Caiola M, Canini A. Crocus sativus L. genomics and different DNA barcode applications. Plant Systematics and Evolution 2013; 299(10): 1859–63
  10. Ahmadian R, Hosseni F, Salami M. Investigation of Physicochemical Properties and Microbial Contamination of Saffron Style. J Pharmaceutical and Health Scie 2016; 4(1): 23–33
  11. Rashed-Mohassel MH. Evolution and botany of saffron (Crocus sativus L.) and allied species. Saffron: Elsevier; 2020.p.37–57
  12. Court WE. The formulary of a West Yorkshire pharmacy 1885-1927. Pharm Hist (Lond) 1997; 27(1): 2–9
  13. Golmohammadi F. Saffron and its farming, economic importance, export, medicinal characteristics and various uses in South Khorasan Province-East of Iran. Int J Farm Allied Sci 2014; 3(5): 566–96
  14. Bazrafshan O, Etedali HR, Moshizi ZGN, MS. Virtual water trade and water footprint accounting of Saffron production in Iran. Agricultural Water Management 2019; 213: 368–74
  15. Alonso G, Zalacain A, Carmona M. Saffron. In: Peter KV, editor. Handbook of Herbs and Spic